Upgrade to SI Premium - Free Trial

After-Hours Stock Movers 12/21: (ALXA) (CTAS) Higher; (SCS) (NTAP) (SYNT) Lower (more...)

December 21, 2015 6:10 PM
Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) 41.2% HIGHER; announced interim results of its Phase 2a study of AZ-002 (Staccato® alprazolam) in ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Special Reports

Next Articles